Trial intelligence / Profile preview

Adjuvanted vs Non-adjuvanted Influenza Vaccines in HIV

NCT07126652Not yet recruiting

Sponsor
National Taiwan University Hospital
Start
Oct 2025
Primary completion
Dec 2026
Modality
Vaccines & Immunotherapeutics
01

Overview

Randomised trial of influenza vaccine + MF59C.1 in influenza (3 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Seroconversion Rate at Day 28. Planned start Oct 2025; status: not yet recruiting.

02

Drugs

influenza vaccine + MF59C.1
03

Conditions

influenza

Beyond the preview

Go deeper on NCT07126652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07126652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call